Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 17 Source: Estimated
- €3.2 billion turnover
- 300 employees
-
31st Dec 16 Source: Estimated
- €188.1 million turnover
- 500 employees
- 3 more years available »
Ranking
By Turnover
(€3.2 billion)- 32nd in Top Companies
- 7th in Health
- 6th in Pharma
By Employees
(300)- 466th in Top Companies
- 68th in Health
- 48th in Pharma
- 300
- €3.2 billion
Employees
- Julie O'Neill Senior vice president
Latest News
- 8:16pm LotusWorks taken over in management buyout
- 7:12pm Aryzta investor calls second egm on €800m rights issue
- 6:59pm Former bank director Bernard Somers settles €1.7m loan action
- 6:47pm MIT plans college for artificial intelligence, backed by $1 billion
- 6:47pm MIT plans $1bn college for artificial intelligence